PSB-12379
CAS: 1802226-78-3
Ref. 3D-CXC22678
| 1mg | 341.00 € | ||
| 5mg | 432.00 € | ||
| 10mg | 616.00 € | ||
| 25mg | 1,035.00 € | ||
| 50mg | 1,656.00 € |
Product Information
PSB-12379 is a potential cancer therapeutic that inhibits the activity of membrane-bound enzymes, including purine nucleoside phosphatase (PNP) and adenosine phosphatase. The compound has been shown to be effective in vitro on cancer cells and may have application in the treatment of neurodegenerative diseases. PSB-12379 is an incompletely excised analogue of adenosine triphosphate (ATP), which has been shown to bind to PNP and inhibit its phosphatase activity. This inhibition leads to accumulation of ATP and activation of purinergic receptors, which are involved in many physiological processes including nerve growth and cancer cell proliferation.
Chemical properties
Technical inquiry about: 3D-CXC22678 PSB-12379
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
